Multidisciplinary approach: Complex cases may benefit from consultation with pulmonology, cardiology, or other specialists
#LifeSciences #Pharma #DrugDelivery #GLP1 #LEXX #BiotechInvesting Lexaria CEO on DehydraTECH and Oral GLP-1s To view or add a comment, sign in Zacks SCR Senior Life Sciences Analyst, John Vandermosten, speaks with Lexaria Bioscience (NASDAQ: LEXX) CEO Rich Christopher about the companys DehydraTECH platform and its potential to transform GLP-1 drug delivery
She graduated from the University of Manchester and completed her GP training through Whipps Cross Hospital in London
5) Saxenda (liraglutide) Approved by the FDA in 2014, Saxenda contains the same active ingredient as Victoza
Mild side effects can include nausea, flushing, dizziness, and localized irritation at the injection site
Lesson Summary Used throughout many hospital settings, bacteriostatic water is a sterile water made to inhibit the growth of bacteria by adding 0.9% benzyl alcohol or a salt solution, which prevent bacteria from growing